This published paper aims to inform vaccine manufacturing and cell substrate residual contaminant levels, insertional mutagenesis and autoimmunity and the relationship these pathological processes to current childhood disease epidemics including autistic disorder, leukemia, lymphoma, intellectual disability, schizophrenia and bipolar disorder.
Changepoint analysis of autism disorder demonstrates a temporal correlation with events associated with human DNA residuals in vaccines. The levels of residual DNA are well over FDA-recommended limits.
This study confirms the 1988 changepoint detected by EPA and adds 1981 and 1996 as additional changepoints. AD birthyear changepoints, particularly 1981 and 1996, cannot be explained by predicted birthyear changepoints based on altered thimerosal content in vaccines nor on revised editions of the DSM. Based on changepoint anaylses, environmental factors introduced universally to children in the US according to the schedule in the table below should be investigated. A prime environmental suspect is the introduction of human DNA contaminants in vaccines introduced to the US in 1979-1983, 1989 and 1995.
The aim of this study was to investigate a previously overlooked, universally introduced environmental factor, fetal and retroviral contaminants in childhood vaccines, absent prior to change points in autistic order prevalence with subsequent dose-effect evidence and known pathologic mechanism of action.
Sound Choice Research
Sound Choice is dedicated to researching the dangers of using aborted fetal material in biologics and seeks alternative treatments and products which are ethically acceptable.
The prevalence of autism in the CDDS dataset, the longest of the three data records, increased from 0.001% in the cohort born in 1931 to 1.2% among 5 year-olds born in 2012. This increase began around ~ 1940 at a rate that has gradually accelerated over time, including notable change points around birth years 1980, 1990 and, most recently, 2007.